IPO liquidity is reopening—but the market is still pricing two different demand regimes

The IPO window is not simply open or closed. It is selective, and the selection mechanism is increasingly visible in the plumbing: which issuers can raise capital, how much secondary supply reaches the tape, how lockups release shares, and whether demand is deep enough to absorb volatility without large price concessions.

The card’s thesis

The evidence this quarter supports a qualified version of the research hypothesis. Demand and earnings growth are clearly supporting parts of the software group, especially DDOG and SNOW. But that strength has not generalized across the basket: CRWV has strong contracted demand and aggressive capacity financing, while consumer and auto-exposure names remain more sensitive to rates, sentiment, and the cost of capital.

That divergence matters for IPOs and secondaries. A healthy primary market can coexist with fragile secondary liquidity when investors are willing to fund proven growth but less willing to absorb duration, leverage, or uncertain demand.

The issuance window is active, but not broad-based

A current IPO calendar shows two deals scheduled for the week of October 11— Iambic Therapeutics and City Therapeutics—with roughly $325 million of combined expected proceeds; the same weekly review reported one listing, five new filings, and two postponements or withdrawals in the prior seven days. Those are useful signs of activity, but they also show why a headline deal count is not the same thing as a uniformly open market.^[1]

Renaissance Capital’s third-quarter review described 30 U.S. listings and $32.8 billion of proceeds, with the proceeds heavily influenced by SK hynix’s $26.5 billion transaction. Its summary attributed the softer fall pickup to concerns about AI spending and higher rates.^[2] The same data set’s year-to-date table reported 114 IPOs of at least $50 million in market capitalization and $147.6 billion of proceeds, but those aggregate proceeds are not a proxy for breadth or aftermarket liquidity.^[2]

The better question is not “are IPOs back?” It is “which business models can clear the market’s current hurdle rate, and what happens when their restricted or newly issued shares become tradable?”

Software demand is the cleanest support for the growth case

The earnings evidence is strongest in the cloud-software portion of the scope.

• DDOG: Management reported Q2 revenue of $1.12 billion, up 36% year over year, and said growth among non-AI customers had accelerated to the high 20s percent year over year. It also reported about 4,720 customers with at least $100,000 of annual recurring revenue, versus roughly 3,850 a year earlier.^[3]
• SNOW: In Q2 fiscal 2027, product revenue growth accelerated to 37% year over year, while net-new customer additions rose 32% year over year. Management described AI as both a direct revenue contributor and a catalyst for core-platform consumption.^[4]

That operating evidence is consistent with the market’s six-month differentiation: DDOG returned 112.72% and SNOW 132.73% from April 17 through October 14, although their annualized volatilities were 71.9% and 67.77%, respectively.^[5] Strong earnings momentum has been rewarded, but the volatility numbers argue against treating that reward as a smooth or low-risk reopening of growth issuance.

CRWV shows the financing side of the market-structure test

CoreWeave is a different case. Its management reported Q2 revenue of $2.6 billion, up 112% year over year, and revenue backlog of $104.2 billion, up 246% year over year. It also said customers were signing longer contracts across older GPU generations and that financing progress had reduced the company’s weighted average cost of capital.^[6]

That is powerful demand evidence, but it is also a capital-markets story. The company’s 2026 plan has involved large infrastructure investment funded through asset-level and other financing structures; its public filings include an S-3 registration statement, and a prospectus supplement describes a potential 35 million-share at-the-market program.^[7] Registration capacity is not the same thing as an executed sale, and neither a backlog figure nor a financing facility eliminates execution, utilization, refinancing, or dilution risk.

The tape reflects that distinction. CRWV fell 43.71% over the same six-month window, with 93.31% annualized volatility and a 55.92% maximum drawdown.^[5] In market-structure terms, this is the difference between demand that is visible in contracts and liquidity that is available at a stable price.

The consumer and auto side still needs confirmation

The rest of the scope is a useful control group for the demand thesis. Over the same period, WSM returned 22.04%, while AN fell 26.35% and RH fell 21.31%; RH’s maximum drawdown was 43.42%.^[5] Those results do not prove a single cause, but they do show that resilient demand is not arriving evenly across software, infrastructure, autos, and home furnishings.

The macro backdrop makes that separation important. The latest snapshot available for this run shows 10-year Treasury yields at 5.24%, CPI inflation at 3.35% year over year, consumer sentiment at 51.7, and a VIX reading of 15.21. Real GDP growth was 2.1% year over year and unemployment was 4.2%.^[8] A calm headline volatility index can coexist with difficult financing conditions for companies whose value depends on long-duration growth or heavy capital deployment.

Lockups, secondaries, and liquidity are the next transmission channel

New supply arrives through more than IPO pricing. The market must also absorb:

A lockup calendar currently lists large releases in October, including ARXS on October 12 and MAIR on October 12, with the published calendar showing the shares eligible to unlock and the associated prospectus terms.^[1] Calendar data should be treated as a starting point: the definitive terms are the prospectus, amendments, and company filings.

Market plumbing matters at the margin. The SEC approved an amendment to the national market-system plan establishing temporary price-band protections for overnight trading, while a later October filing addressed the timing used to calculate the consolidated price in overnight trading.^[9] Separately, NYSE research on smaller round lots found that reduced lot sizes tightened spreads in affected securities but decreased liquidity at the top of book and deeper levels, making larger trades more difficult and costly to execute.^[9]

These are not directional signals. They are reminders that displayed spreads, executable depth, overnight protections, and the timing of new supply can shape the path from a strong business update to a tradable market price.

What the hypothesis has—and has not—earned

Evidence for: DDOG and SNOW show accelerating usage, customer expansion, and AI-linked consumption in management commentary. CRWV reports unusually large contracted demand and capacity pricing power.^[3][4][6]

Evidence against or still unresolved: CRWV’s share-price performance and volatility show that contract visibility does not automatically translate into stable equity liquidity. The consumer and auto names have not confirmed a broad demand acceleration, and macro conditions still impose a high hurdle for long-duration or capital-intensive issuance.^[5][8]

The base-rate conclusion is therefore conditional: earnings growth can support selected new listings and secondaries, but the market is likely to discriminate sharply by cash-flow visibility, balance-sheet funding, float, and the timing of insider or pre-IPO holder supply.

What to watch next

1. The next primary-market test: whether the October IPO calendar converts announced candidates into priced deals without repeated postponements, and how first-week turnover compares with the offered float.
2. The supply calendar: lockup releases, Rule 144 notices, selling-stockholder registrations, ATM usage, and follow-on pricing—especially where the newly eligible supply is large relative to the public float.
3. Earnings confirmation: DDOG is scheduled to report on November 5, estimated before the open; SNOW is scheduled for December 2, estimated after the close; AN is scheduled for October 30, estimated before the open, with October 22 listed as an alternate. RH and WSM are scheduled for December 10 and November 18, respectively, both estimated; LZB is scheduled for November 17, estimated after the close. CRWV is unsupported by the earnings-calendar source used here, so no date is stated.^[10]
4. Demand quality: whether software consumption becomes durable production usage rather than pulled-forward experimentation, whether CRWV converts backlog into revenue and cash flow, and whether consumer demand improves without a meaningful easing in financing pressure.
5. Liquidity quality: depth beyond the best quote, overnight price-band events, realized volatility around unlocks, and whether buybacks actually offset new issuance rather than merely receiving authorization.

The IPO window can widen from here, but the evidence does not yet support treating issuance, liquidity, and demand as one market. The more useful map is two-speed: operating momentum is strongest in software, while capital intensity, consumer sensitivity, and supply mechanics determine how much of that momentum can be absorbed by public markets.